Geoffrey Benic, CEO, acquired 182,000 Common Shares on a direct ownership basis at prices ranging from $0.414 to $0.419 between March 26th, 2020 and March 27th, 2020. The insider also acquired 57,000 Common Shares on a direct ownership basis at a price of $0.315USD on March 27th, 2020. This represents a $101,296 investment into the company's shares and an account share holdings change of greater than 100%.
Julian Fantino, a Senior Officer and Director, acquired 62,000 Common Shares on a direct ownership basis at a price of $0.390 on March 30th, 2020. This represents a $24,180 investment into the company's shares and an account share holdings change of 1.4%.
Robert van den Heuvel, a Senior Officer, acquired 10,800 Common Shares on a direct ownership basis at a price of $0.390 on March 26th, 2020. This represents a $4,212 investment into the company's shares and an account share holdings change of greater than 100%.
Nicholas Bergamini, a Senior Officer, acquired 2,400 Common Shares on a direct ownership basis at a price of $0.420 on March 27th, 2020. This represents a $1,008 investment into the company's shares and an account share holdings change of 15.3%.
Aleafia Health is in the Healthcare Facilities & Services Sub Industry Group under the Healthcare Sector.
Aleafia Health Inc is a Canada-based vertically integrated, national cannabis company with medical clinic, cannabis cultivation and Research and Development (R&D ) operations. The Company operates a number of medical cannabis clinics staffed by physicians and nurse practitioners. The Company is differentiated, maintaining the medical cannabis dataset in the world with intellectual property holdings and current R&D operations.
No Comments